A new study suggests that a machine designed to copy the human sense of smell could one day help doctors detect ovarian cancer much earlier than before.
Researchers from Linköping University in Sweden have created an electronic nose that can find warning signs of the disease in a simple blood sample.
This technology uses artificial intelligence to study tiny chemical traces that cancers release into the body.
Ovarian cancer is especially dangerous because it is often found late. The early symptoms are usually mild and easy to ignore, such as bloating, stomach pain, or feeling full quickly. Many women think these problems are caused by diet or stress, so they do not seek medical help right away.
By the time the disease is diagnosed, it may already have spread, which makes treatment more difficult and lowers survival chances. Each year, hundreds of thousands of women around the world are diagnosed, and many die because doctors could not catch the disease early enough.
The electronic nose works by detecting very small chemical particles in the blood. These particles are released by cells as they function, and diseases can change the types and amounts that appear.
Different cancers produce different chemical patterns, almost like having their own invisible smell. Humans cannot sense these smells, but sensitive sensors can. The device used in the study contains many tiny sensors that react to these substances and send signals to a computer.
Machine learning software then analyzes the signals and searches for patterns linked to ovarian cancer. The system was trained using blood samples from both healthy people and cancer patients.
Over time, it learned to recognize the differences between them. In this early research, the test correctly identified ovarian cancer in about 97 percent of cases, which is a very high accuracy rate for a new screening method. It could also tell the difference between ovarian cancer and other similar conditions, which is important for avoiding misdiagnosis.
One of the biggest advantages of this approach is that it is quick and simple. The test takes only about 10 minutes and does not require complicated laboratory procedures.
Current screening methods often rely on searching for a single substance in the blood, which may not appear until the disease is advanced. By looking at many chemical signals at once, the electronic nose may detect cancer earlier and more reliably.
This technology could also make screening more accessible. Because the sensors are relatively simple and already available on the market, the test could be offered at a lower cost than many existing methods. This means it might be used in smaller clinics and in regions with limited medical resources, helping more people receive early diagnosis.
However, the researchers stress that this study is only a first step. Larger studies involving more patients are needed to confirm that the test works safely and consistently.
Doctors must also ensure that the results are accurate enough to avoid false alarms that could cause unnecessary worry or treatment. If future research confirms these findings, the electronic nose could become part of routine cancer screening within a few years.
The study shows how combining medical science with artificial intelligence can create powerful new tools for health care. A fast and affordable test that finds cancer early could save many lives and improve quality of life for patients.
While more research is needed, the results are encouraging and suggest that technology may soon help doctors detect diseases in ways that were once impossible.
Overall, the findings are promising because they offer a new direction for cancer detection, especially for diseases that are difficult to diagnose early.
The high accuracy reported in this pilot study suggests real potential, but scientists must carefully test the method in larger populations to confirm its reliability. If proven effective, this approach could transform screening programs and give patients a much better chance of survival through earlier treatment.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and berry that can prevent cancer, diabetes, and obesity.
For more health information, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing vitamin D supplements could strongly reduce cancer death.
The study is published in Advanced Intelligent Systems.
Copyright © 2026 Knowridge Science Report. All rights reserved.
